Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Verily Ranked #1 for Interesting & Meaningful Work and Competitive Salary

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

The opportunity to work at the leading edge of science and technology while working on solutions to some of the world's most vexing problems is what attracts people to Verily.…

Continue ReadingVerily Ranked #1 for Interesting & Meaningful Work and Competitive Salary

Regeneron Gets OK for Huge Expansion in Greenburgh, New York

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

When complete, the expansion is expected to double the size of Regeneron's footprint in Greenburgh. Source: BioSpace

Continue ReadingRegeneron Gets OK for Huge Expansion in Greenburgh, New York

Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace

Continue ReadingFounded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M

Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace

Continue ReadingPhiladelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately

San Diego's Mirati Therapeutics Abandons Lead Drug, Shifts Focus

  • Post author:Sam
  • Post published:November 14, 2017
  • Post category:BioPharma

Two months after positive preliminary data showed sitravatinib in combination with Opdivo demonstrated some efficacy in treating patients with NSCLC, Mirati said it will reprioritize its R&D to focus. Source:…

Continue ReadingSan Diego's Mirati Therapeutics Abandons Lead Drug, Shifts Focus

Meet the 5 Bay Area Biotech Entrepreneurs Under 30

  • Post author:Sam
  • Post published:November 14, 2017
  • Post category:BioPharma

Every year, Forbes creates lists of "30 Under 30" leaders in various industries who are under the age of 30. Source: BioSpace

Continue ReadingMeet the 5 Bay Area Biotech Entrepreneurs Under 30

Amgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks

  • Post author:Sam
  • Post published:November 14, 2017
  • Post category:BioPharma

Data from Amgen's Fourier study supports the use of Repatha to reduce the risk of recurrent cardiovascular events in patients with a history of multiple heart attacks. Source: BioSpace

Continue ReadingAmgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks

Genentech Dumps Another $650M in New Haven Biotech Arvinas

  • Post author:Sam
  • Post published:November 14, 2017
  • Post category:BioPharma

Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace

Continue ReadingGenentech Dumps Another $650M in New Haven Biotech Arvinas

How We Talk about Science and Science Denial

  • Post author:Sam
  • Post published:November 14, 2017
  • Post category:BioPharma

We write about science every day, why isn’t it getting through to the public consciousness? Source: BioSpace

Continue ReadingHow We Talk about Science and Science Denial

Sangamo Scores Bragging Rights for First-in-Human Gene Editing Trial

  • Post author:Sam
  • Post published:November 14, 2017
  • Post category:BioPharma

Barely a week after announcing it was moving into a new corporate headquarters, Sangamo announced it has dosed the first patient in its Phase I/II gene therapy trial. Source: BioSpace

Continue ReadingSangamo Scores Bragging Rights for First-in-Human Gene Editing Trial
  • Go to the previous page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.